Objectives: Individualized treatment for bipolar disorder based on neuroimaging treatment targets remains elusive. To address this shortcoming, we developed a linguistic machine learning system based on a cascading genetic fuzzy tree (GFT) design called the LITHium Intelligent Agent (LITHIA). Using multiple objectively defined functional magnetic resonance imaging (fMRI) and proton magnetic resonance spectroscopy ( 1 H-MRS) inputs, we tested whether LITHIA could accurately predict the lithium response in participants with first-episode bipolar mania.
| INTRODUCTION
Bipolar disorder is a common, lifelong, and recurrent illness, with lifetime prevalence rates up to 6% of the population when considering subthreshold mood symptoms. 1, 2 Although it is characterized by episodic mood dysregulation that fluctuates among manic, depressive, and euthymic (i.e., relatively symptom free) mood states, it is defined by the occurrence of mania. Patients experience an especially high degree of morbidity and mortality during manic episodes, 3 highlighting the need to identify effective anti-manic treatments quickly.
Lithium is the oldest mood stabilizer and well established as a firstline anti-manic agent. Indeed, lithium is the only psychotropic agent specific to the treatment of bipolar disorder, 3 making it uniquely suited for outcomes research targeting mania reduction. It is also particularly effective early in the course of illness. 4 Nonetheless, many patients do not respond adequately to a trial of lithium monotherapy, and in the absence of reliable predictors of response, these patients are exposed to side effect risks without the benefit of eventual treatment response.
Despite the long history of lithium treatment for bipolar disorder, objective biological markers (i.e., blood or genetic markers) of potential treatment responsiveness to lithium and, indeed, all mood stabilizers have been lacking. Therefore, identifying an optimal treatment for an individual with bipolar disorder remains a time-consuming trial-anderror process. 5 This approach is especially true after a first manic episode, which is necessary for the initial diagnosis of bipolar disorder, as there is little indication of which mood stabilizer class (e.g., lithium, second-generation antipsychotic agents, or anticonvulsants) might be most beneficial in a given individual in the absence of a treatment response history.
With advances in neuroimaging, there has been considerable interest in brain markers of treatment effectiveness in serious mental
illness. Yet, imaging research has failed to provide brain-based indicators of treatment response (or diagnosis) in bipolar disorder to date.
One way forward has been to combine multiple clinical measures into a data-driven analytical approach to differentiate groups based on the pattern of relationships among measures. 6 The data are then included as inputs in a bottom-up classification algorithm to find the best separation between groups. Traditionally, linear pattern classification has been conducted using inferential statistics, such as discriminant function analysis, or using support vector machines (SVMs), but these have yet to identify predictors for lithium response. Only more recently has machine learning applied non-linear solutions of large-scale bioinformatics problems, which is important for the study of bipolar disorder, where relationships among neurocognitive measures and symptoms are often non-linear. 7 Moreover, these newer algorithms are specifically tailored to situations in which the number of inputs vastly exceeds the sample size, 8 as is often the case in neuroimaging research.
With the above considerations in mind, we examined whether a new machine learning system based on a cascading genetic fuzzy tree (GFT) design could be used to predict the lithium response in subjects with first-episode mania. Limitations inherent to standard fuzzy logicbased machine learning systems stem, in part, from scalability issues.
This problem derives from the need for a rule to be "learned" for every combination of values of membership functions for each input. The GFT method we employed for the present study mitigates these scalability concerns significantly by breaking the problem space into many sub-decisions. Thus, the GFT is vastly more scalable than traditional fuzzy logic-based systems and maintains the base strengths of fuzzy logic: robustness to noise and subjectivity, adaptability of lessons learned from training, and high performance of final outputs. For the present study, prediction was based on a set of objective pre-treatment neuroimaging parameters, including relative functional magnetic resonance imaging (fMRI) activation and magnetic resonance spectroscopy (MRS) metabolite levels in various brain regions in a data-driven design. Enhanced classification accuracy using the GFT approach might have helped to avoid unnecessary treatment, time, and expense in the subset of lithium non-responsive patients with bipolar disorder. Fifteen subjects were less than 18 years old at the time of the scan.
| METHODS

| Participants
Subjects were included if they: (i) were 12-35 years old; (ii) met DSM-IV criteria for bipolar I disorder, currently manic or mixed with a baseline Young Mania Rating Scale (YMRS) 10 total score ≥20; (iii) had no prior manic episodes and ≤2 prior depressive episodes; (iv) had no previous psychiatric hospitalizations; (v) had <3 months of lifetime psychotropic medication exposure, other than stimulants, including no active psychotropic medication in the 2 weeks prior to the index admission;
and (vi) no contraindication to taking lithium. Subjects were excluded by: (i) a history of substance dependence within 3 months prior to the index assessment; (ii) any medical or neurological disorder that could affect fMRI assessments; (iii) a history of significant developmental delays or estimated full-scale intelligence quotient score <85; or (iv) a contraindication to an MRI scan. We have recently reported imaging findings in a larger sample both of lithium-and quetiapine-treated patients, of which all patients in the present analysis were also included. 
| Clinical assessments
Diagnostic assessments were performed using the Structured Clinical
Interview for DSM-IV, Patient version (SCID-P) 11 or, for subjects under 18 years old, the Washington University Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age Children-
Present and Lifetime version (KSADS).
12 Substance use assessments were augmented with the Addiction Severity Index (ASI). 13 Manic symptoms were evaluated using the YMRS as noted. Changes in YMRS total scores between baseline and week 8 served as the treatment response measure of interest. Lithium response was defined as at least a 50% improvement between baseline pre-treatment and week 8 post-treatment YMRS scores.
| Lithium treatment protocol
Subjects received open-label lithium for 8 weeks. Lithium was chosen because it is a first-line Food and Drug Administration-approved treatment for mania in children and adults with specific anti-manic effects. Open-label treatment was initiated during the index hospitalization and then continued following hospital discharge throughout the course of the study. Doses were adjusted by study clinicians based upon serum drug levels (the target was 0.8-1.2 meq/L) and treatment response and tolerability. Adherence was verified by participant report, pill counts, and serum levels when indicated.
| Continuous performance task with emotional and neutral distractors (CPT-END)
During fMRI sessions, non-ferromagnetic goggles were positioned on subjects to provide clear visualization of the CPT-END. As shown in Figure 1 , prior to treatment, fMRI regions-of-interest (ROIs) were established using voxel-wise contrasts between a larger sample of healthy (n=41) and first-episode manic participants (n=42) at baseline. 9 Specifically, these analyses were completed in AFNI based upon Monte Carlo simulation using 10 000 iterations from which significant activation differences between groups were defined as P<.001
| fMRI acquisition
with a cluster of 30 voxels that resulted in a corrected threshold of
P<.01.
14 From this analysis, in order to define ROIs, spheres of 15 mm diameter were placed, centered on the voxel of maximum activation within identified clusters that differed between groups. A Gaussian blur with a full width at half maximum (FWHM) of 6 mm was applied.
The percentage signal change in activation served as the variable of interest. We chose this approach to reduce the number of machine learning inputs, reduce data dimensionality, and identify ROIs that may have represented more likely targets of lithium treatment.
| Proton MRS ( 1 H-MRS) acquisition
A 1 H-MRS scan was obtained immediately following the fMRI scan on the same system used for fMRI. A 1 H transverse electromagnetic (TEM) head volume coil was used as a transmitter/receiver.
A multi-slice scout image was initially acquired for positioning and 1 H-MRS voxel placement. The scout image was followed by acquisition of a 3-D whole head MRI using a modified driven equilibrium Fourier transform (MDEFT) pulse sequence for tissue segmentation (TR=13.1 ms, TE=6 ms, (MDEFT preparation time) TMD=1.1 ms, data matrix=256×192×192, FOV=256×192×150 mm, slab thickness=150 mm, axial orientation, and 32 segments). 17 For MRS data acquisition, the magnetic field homogeneity was optimized using a powers and optimizing relaxation delays (VAPOR) method. 21 For computations of metabolite levels and eddy current correction, one reference spectrum without water suppression was collected at the same voxel positions using the same parameters, except with four averages and reduced receiver gain.
| 1 H-MRS processing
Standard 1 H-MRS spectra were obtained at each of three ROI locations and included N-acetyl-asparate, myo-inositol, glutamate (Glu), Glx (Glu+glutamine), choline, and creatine. To calculate each neurometabolite, localized spectra were curve fitted using linear combination of model spectra (LCModel) using the reference of water signal in unsuppressed-water spectra. 22 Data were corrected with T1 and T2 relaxation losses using previously published values. 23 To clarify the influence of tissue heterogeneity, metabolite levels were corrected using tissue segmentation data. Metabolite levels were computed and presented as concentration (mM) with the water reference of the unsuppressed-water spectra. Differences in water concentrations, and T1 and T2 relaxation times in gray matter, white matter, and cerebrospinal fluid were also taken into consideration for the computation.
To determine the tissue contents within voxels, MDEFT images were processed using a contrast-driven algorithm executed using SPM2
(Statistical Parametrical Mapping; http://www.fil.ion.ucl.ac.uk/spm/).
| Machine learning methodology
For the present study, we developed a new linguistic machine learning system based on a cascading GFT design called the LITHium Intelligent Agent (LITHIA). As seen in Table 1 , the methodology employed for LITHIA was an evolution of genetic algorithms 24 and fuzzy systems.
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Our GFT methodology helps to mitigate scalability concerns of standard genetic fuzzy systems by breaking the problem space into many sub-decisions. Variables that are directly coupled are placed in the same part of the controller, while "slightly" coupled variables are, at least, placed in the same branch of the tree structure to offset any decrease in accuracy due to unaccounted-for coupling between variables. Although any genetic algorithm can be utilized to train a system such as LITHIA in theory, for the reasons stated above, the EVE learning system (Psibernetix Inc., Liberty Township, OH, USA; http://www.
psibernetix.com/services) was utilized in the present study. EVE is a patent-pending GFT with a fitness function for optimizing or training other similar GFTs through recursive application. [26] [27] [28] Initially, LITHIA was trained using the baseline YMRS total score, 18 MRS inputs, 90 fMRI inputs, and gender as inputs over four training runs. Each training run contained a randomly selected 80% of the total sample (n=16) with the stipulation that it included at least four non-responders. The model was constrained to four lateral levels or "branches", including one each for MRS, fMRI circle (target), fMRI emotional, and fMRI neutral data. It was also constrained to three inputs from a directly higher level, which resulted in up to 125 linguistic "if-then statements" controlling any given fuzzy inference system (FIS;
this was done to limit the computational cost of any FIS in particular, not necessarily with respect to the cost of evaluating that FIS for a given set of inputs, but rather for the cost associated with training a FIS of such immense size). Each FIS classified states (i.e., activation and metabolite level) into a number of membership functions (i.e., very low, low, medium, high, very high). It then created if-then statements (e.g., if the left amygdala response to emotional stimuli is very high, and the right VLPFC response is low, then the YMRS reduction is very high), and these logic-based rules were used to control the system.
Over training, then, these rule bases were learned and the membership functions were tuned and optimized.
Neuroimaging values were provided to EVE, which was utilized to train LITHIA to identify each participant's binary classification (yes or no), and continuous percentage YMRS reduction accuracy (0%-100%).
For each of n patients, the absolute value of % YMRS reduction was summed with either 1 or 0 if correctly classified as response, given a 50% reduction threshold. As a result, LITHIA was trained to minimize the following function:
The prediction accuracy, including sensitivity and specificity, was calculated.
Despite our data reduction approach for the fMRI ROIs, the number of input or predictor variables still greatly outnumbered the number of observations. While optimally a larger training set would be obtained, fuzzy logic has been demonstrated to be robust in training for complex problems with small sets of data or cases. 
| RESULTS
| Participant characteristics and clinical response
We identified 20 subjects with bipolar disorder who had received 
| LITHIA post-training model
| LITHIA training and validation results over four experimental runs
Raw classification data for four separate 80% training and 20% validation runs appear in Appendix 1. In training, LITHIA correctly classified patients as responders or non-responders with 100% accuracy Genetic algorithm (GA) • Inspired by evolution and survival of the fittest.
• Optimization method that quickly searches solution space.
• Resilient to local optima Fuzzy inference system (FIS)
• Uses linguistic reasoning to control a system.
• Data belong to sets in a non-binary method (0,1).
• Robust to uncertainty, high performance, efficient
Genetic fuzzy system (GFS)
• Uses GA to create or optimize an FIS.
• Can create the if-then rules normally provided by expertise.
• Well-proven method, compared to linear, neural network, etc.
Genetic cascading fuzzy system • GA creates or optimizes multiple FISs in cascade.
• Layers of FISs hierarchically break down problem.
• Allows fuzzy logic to solve complex problems efficiently GFT • Uses GA to create or optimize a tree of multiple cascades.
• Brings learning of GFS to incredibly complex problems.
• Maintains strengths of all sub-methods T A B L E 1 Methodologies underlying the final genetic fuzzy tree (GFT) structure of the LITHium Intelligent Agent (LITHIA) 
| LITHIA vs eight deterministic comparison methods: training results
Over a different distribution of the 20 subjects, LITHIA was compared to eight common classification methods. In the interest of space, raw training data are not presented in tabular form here (data available from the corresponding author upon request), but instead overall classification and mean YMRS reduction accuracy is reported. 
| LITHIA vs eight deterministic comparison methods: validation results
Raw
| DISCUSSION
The present pilot study was conducted to obtain preliminary data and proof-of-concept that a novel machine learning system based on a genetic algorithm and fuzzy logic is capable of accurately classifying 
showed a strong predictive capability. Even with only 20 participants, LITHIA was able to apply control to the problem using linguistic rules.
The system demonstrated nearly perfect classification accuracy and was able to predict post-treatment symptom reductions at 8 weeks with at least 88% accuracy in training and 80% accuracy in validation. Moreover, LITHIA exceeded the predictive capacity of each of the eight comparison methods, on average. Not only was it the only method to achieve 100% classification accuracy in the validation run, but it was also twice as accurate in predicting average symptom reduction scores in validation, and showed little tendency towards overfitting. Although LITHIA was not statistically superior to the comparator methods in validation, the small validation set (n=4) employed for this pilot study may necessitate a more qualitative interpretation approach in light of low power. We are still working on visualization functionality but, unlike other classification methods, linguistic rules with weighted importance can be provided by LITHIA, along with the relative importance of inputs. LITHIA can directly explain why a prediction was given in English sentences, with no translation necessary, which will allow individuals who are untrained in intelligent systems to make use of the technology.
To our knowledge, these results are the first employing machine learning to predict treatment response in bipolar disorder. Indeed, there have been few machine learning studies to predict treatment response in the whole of psychiatry, probably due to the cost of incorporating brain indices in longitudinal treatment designs. In one prior study of patients with major depressive disorder, machine learning was employed to predict selective serotonin reuptake inhibitor (SSRI) treatment response using quantitative electroencephalogram (qEEG) to good effect (accuracy=88%, sensitivity=95%, specificity=81%). 31 However, in an early study using non-objective, observational data to predict fluoxetine treatment outcomes with an artificial neural network (ANN), the ANN was unable to predict clinical outcome.
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These findings support the notion that: (i) newer machine learning applications may better predict outcome than their predecessors; and (ii) objective biomarkers are likely to be superior to subjective ones in bioinformatics applications.
In contrast to the dearth of treatment response studies, numerous diagnostic classification studies have employed Gaussian process classifier, SVMs, and least absolute shrinkage and selection operator (LASSO) methods to predict diagnostic membership. However, research to classify different combinations of bipolar disorder, major depressive disorder, and schizophrenia patients based on objective neuroimaging parameters has met with mixed success. Obtained accuracy, sensitivity, and specificity indices have all ranged between 50% and 100%, [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] suggesting that these methods are still limited. Future research building on newer methodologies incorporating genetic algorithms and GFTs, such as LITHIA, may help to overcome some of the shortcomings of prior generation classification methods.
As with all research, the present study had limitations. First, these data were not validated using either a leave-one-out (LOO) cross-validation method or on an independent cohort of lithiumtreated bipolar subjects, which is the gold-standard validation Fifth, without a control group, it is difficult to ascertain whether mania symptom reductions resulted from lithium treatment, natural episode resolution within the 8-week period, or other time-locked factors. Finally, although not specific to the present study, a lack of standardization of operating conditions (e.g., magnet strengths, number of head coil channels, software) can result in data that may not be comparable across sites. 
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